Technologies in Diabetes & AID
Leading global clinical research on Automated Insulin Delivery (Artificial Pancreas), Continuous Glucose Monitoring (CGM), smart sensors, and algorithm-driven glycemic management.
Transforming Diabetes Through Technology
From introducing early continuous subcutaneous insulin infusions (CSII) in India to pioneering advanced hybrid closed-loop artificial pancreas systems, JDC is at the forefront of diabetes tech research.
Automated Insulin Delivery (AID)
Pioneering real-world clinical evaluations of hybrid closed-loop algorithms (Artificial Pancreas) that automatically modulate basal insulin rates in response to real-time sensor glucose trends.
Continuous Glucose Monitoring
Clinical benchmarking of real-time CGM and Flash Glucose Monitoring (FGM) systems, establishing accuracy (MARD), sensor longevity, and impact on Time-in-Range (TIR) metrics.
Time in Range (TIR) & AGP
Pioneering Ambulatory Glucose Profile (AGP) interpretation protocols, replacing reliance on HbA1c alone with standardized Time in Range (>70% in 70–180 mg/dL) and glycemic variability indices.
Smart Insulin Pens & Caps
Evaluating Bluetooth-connected smart pens, dose calculators, and automated injection logging devices that prevent missed doses and stacking in Multiple Daily Injection (MDI) regimens.
Cloud Analytics & Telemetry
Integration of device cloud ecosystems with clinic EMRs, enabling automated pattern detection, predictive hypoglycemia alerts, and remote telemedicine consultations.
Global Guidelines & Consensus
JDC investigators actively author global consensus guidelines on insulin pump therapy, CGM metrics, and digital health adoption in international forums (ATTD, ADA, EASD, RSSDI).
Over 100+ Publications in Diabetes Technology
Explore original research articles, randomized trials, and consensus guidelines on insulin pumps and CGM authored by JDC scientists in Diabetes Care, The Lancet Diabetes & Endocrinology, and Diabetes Technology & Therapeutics.
Our Hospital & Research Branches
Accessible, world-class comprehensive diabetes care and clinical research across 5 strategic locations.